Multiresistant organisms: bacteria and beyond
Curr Opin Organ Transplant. 2022 Mar 11. doi: 10.1097/MOT.0000000000000976. Online ahead of print.ABSTRACTPURPOSE OF REVIEW: Infections with multiresistant organisms are an emerging problem, cause early mortality post lung transplantation and are sometimes associated with graft dysfunction. Frequently they raise questions about the selection of lung transplant candidates and therapeutic management post lung transplantation. There are no guidelines and management must be individualized. This review summarizes the available therapeutic options in cases of multidrug-resistant (MDR) organisms and outcomes after lung transplant...
Source: Current Opinion in Organ Transplantation - March 14, 2022 Category: Transplant Surgery Authors: Amparo Sole Source Type: research
Multiresistant organisms: bacteria and beyond
Curr Opin Organ Transplant. 2022 Mar 11. doi: 10.1097/MOT.0000000000000976. Online ahead of print.ABSTRACTPURPOSE OF REVIEW: Infections with multiresistant organisms are an emerging problem, cause early mortality post lung transplantation and are sometimes associated with graft dysfunction. Frequently they raise questions about the selection of lung transplant candidates and therapeutic management post lung transplantation. There are no guidelines and management must be individualized. This review summarizes the available therapeutic options in cases of multidrug-resistant (MDR) organisms and outcomes after lung transplant...
Source: Current Opinion in Organ Transplantation - March 14, 2022 Category: Transplant Surgery Authors: Amparo Sole Source Type: research
Multiresistant organisms: bacteria and beyond
Curr Opin Organ Transplant. 2022 Mar 11. doi: 10.1097/MOT.0000000000000976. Online ahead of print.ABSTRACTPURPOSE OF REVIEW: Infections with multiresistant organisms are an emerging problem, cause early mortality post lung transplantation and are sometimes associated with graft dysfunction. Frequently they raise questions about the selection of lung transplant candidates and therapeutic management post lung transplantation. There are no guidelines and management must be individualized. This review summarizes the available therapeutic options in cases of multidrug-resistant (MDR) organisms and outcomes after lung transplant...
Source: Current Opinion in Organ Transplantation - March 14, 2022 Category: Transplant Surgery Authors: Amparo Sole Source Type: research
Multiresistant organisms: bacteria and beyond
Curr Opin Organ Transplant. 2022 Mar 11. doi: 10.1097/MOT.0000000000000976. Online ahead of print.ABSTRACTPURPOSE OF REVIEW: Infections with multiresistant organisms are an emerging problem, cause early mortality post lung transplantation and are sometimes associated with graft dysfunction. Frequently they raise questions about the selection of lung transplant candidates and therapeutic management post lung transplantation. There are no guidelines and management must be individualized. This review summarizes the available therapeutic options in cases of multidrug-resistant (MDR) organisms and outcomes after lung transplant...
Source: Current Opinion in Organ Transplantation - March 14, 2022 Category: Transplant Surgery Authors: Amparo Sole Source Type: research
Multiresistant organisms: bacteria and beyond
Curr Opin Organ Transplant. 2022 Mar 11. doi: 10.1097/MOT.0000000000000976. Online ahead of print.ABSTRACTPURPOSE OF REVIEW: Infections with multiresistant organisms are an emerging problem, cause early mortality post lung transplantation and are sometimes associated with graft dysfunction. Frequently they raise questions about the selection of lung transplant candidates and therapeutic management post lung transplantation. There are no guidelines and management must be individualized. This review summarizes the available therapeutic options in cases of multidrug-resistant (MDR) organisms and outcomes after lung transplant...
Source: Current Opinion in Organ Transplantation - March 14, 2022 Category: Transplant Surgery Authors: Amparo Sole Source Type: research
Multiresistant organisms: bacteria and beyond
Curr Opin Organ Transplant. 2022 Mar 11. doi: 10.1097/MOT.0000000000000976. Online ahead of print.ABSTRACTPURPOSE OF REVIEW: Infections with multiresistant organisms are an emerging problem, cause early mortality post lung transplantation and are sometimes associated with graft dysfunction. Frequently they raise questions about the selection of lung transplant candidates and therapeutic management post lung transplantation. There are no guidelines and management must be individualized. This review summarizes the available therapeutic options in cases of multidrug-resistant (MDR) organisms and outcomes after lung transplant...
Source: Current Opinion in Organ Transplantation - March 14, 2022 Category: Transplant Surgery Authors: Amparo Sole Source Type: research
Multiresistant organisms: bacteria and beyond
Curr Opin Organ Transplant. 2022 Mar 11. doi: 10.1097/MOT.0000000000000976. Online ahead of print.ABSTRACTPURPOSE OF REVIEW: Infections with multiresistant organisms are an emerging problem, cause early mortality post lung transplantation and are sometimes associated with graft dysfunction. Frequently they raise questions about the selection of lung transplant candidates and therapeutic management post lung transplantation. There are no guidelines and management must be individualized. This review summarizes the available therapeutic options in cases of multidrug-resistant (MDR) organisms and outcomes after lung transplant...
Source: Current Opinion in Organ Transplantation - March 14, 2022 Category: Transplant Surgery Authors: Amparo Sole Source Type: research
Burkholderia orbicola sp. nov., a novel species within the Burkholderia cepacia complex
Arch Microbiol. 2022 Feb 17;204(3):178. doi: 10.1007/s00203-022-02778-0.ABSTRACTGenome analysis of strains placed in the NCBI genome database as Burkholderia cenocepacia defined nine genomic species groups. The largest group (259 strains) corresponds to B. cenocepacia and the second largest group (58 strains) was identified as "Burkholderia servocepacia", a Burkholderia species classification which has not been validly published. The publication of "B. servocepacia" did not comply with Rule 27 and Recommendation 30 from the International Code of Nomenclature of Prokaryotes (ICNP) and have errors in the type strain name and...
Source: Archives of Microbiology - February 17, 2022 Category: Microbiology Authors: Leslie-Mariana Morales-Ru íz Mariana Rodr íguez-Cisneros Jeniffer-Chris Kerber-D íaz Fernando-Uriel Rojas-Rojas J Antonio Ibarra Paulina Estrada-de Los Santos Source Type: research
Burkholderia orbicola sp. nov., a novel species within the Burkholderia cepacia complex
Arch Microbiol. 2022 Feb 17;204(3):178. doi: 10.1007/s00203-022-02778-0.ABSTRACTGenome analysis of strains placed in the NCBI genome database as Burkholderia cenocepacia defined nine genomic species groups. The largest group (259 strains) corresponds to B. cenocepacia and the second largest group (58 strains) was identified as "Burkholderia servocepacia", a Burkholderia species classification which has not been validly published. The publication of "B. servocepacia" did not comply with Rule 27 and Recommendation 30 from the International Code of Nomenclature of Prokaryotes (ICNP) and have errors in the type strain name and...
Source: Archives of Microbiology - February 17, 2022 Category: Microbiology Authors: Leslie-Mariana Morales-Ru íz Mariana Rodr íguez-Cisneros Jeniffer-Chris Kerber-D íaz Fernando-Uriel Rojas-Rojas J Antonio Ibarra Paulina Estrada-de Los Santos Source Type: research
Managing Pulmonary Infection in Adults With Cystic Fibrosis: Adult Cystic Fibrosis Series
This article aims to discuss the current evidence and recommended strategies for treating airway infection in CF, focusing on bacterial infections.PMID:35167860 | DOI:10.1016/j.chest.2022.02.007 (Source: Chest)
Source: Chest - February 15, 2022 Category: Respiratory Medicine Authors: Heather D Green Andrew M Jones Source Type: research
Managing Pulmonary Infection in Adults With Cystic Fibrosis: Adult Cystic Fibrosis Series
This article aims to discuss the current evidence and recommended strategies for treating airway infection in CF, focusing on bacterial infections.PMID:35167860 | DOI:10.1016/j.chest.2022.02.007 (Source: Chest)
Source: Chest - February 15, 2022 Category: Respiratory Medicine Authors: Heather D Green Andrew M Jones Source Type: research
Evaluating the alginate oligosaccharide (OligoG) as a therapy for Burkholderia cepacia complex cystic fibrosis lung infection
The Burkholderia cepacia complex (Bcc) comprises greater than 20 species of bacteria [1] that are found in the natural environment including, B. cenocepacia, B. multivorans, B. vietnamiensis, B. dolosa, and B. cepacia. This group are notorious drug resistant/insensitive opportunistic pathogens and a major cause of morbidity and mortality in cystic fibrosis (CF) patients [2]. While infection control policies and patient awareness [3 –5] has highlighted the challenges and led to more effective clinical management measures, infection with Bcc remains a significant clinical challenge in CF [6,7]. (Source: Journal of Cystic Fibrosis)
Source: Journal of Cystic Fibrosis - January 24, 2022 Category: Respiratory Medicine Authors: Rianald Fischer, Carsten Schwarz, Rebecca Weiser, Eshwar Mahenthiralingam, Knut Smerud, Nils Meland, Hugo Flaten, Philip D Rye Tags: Short Communication Source Type: research
Microbiological characteristics and outcomes of children with pleural empyema admitted to a tertiary hospital in southeast China, 2009-2018
CONCLUSIONS: Staphylococcus aureus and Streptococcus pneumoniae were the leading cause of pleural empyema. Antimicrobial susceptibility testing revealed a high percentage of resistance against penicillin while vancomycin provided 100% coverage for these pathogens. Pseudomonas aeruginosa is the third most common pathogen mainly detected in those under 3 years old in the summer and have shown to be susceptible to ceftazidime. The prognosis is good after appropriate therapy.PMID:35023649 | DOI:10.24953/turkjped.2021.06.007 (Source: The Turkish Journal of Pediatrics)
Source: The Turkish Journal of Pediatrics - January 13, 2022 Category: Pediatrics Authors: Xueya Zhang Hailin Zhang Source Type: research
Microbiological characteristics and outcomes of children with pleural empyema admitted to a tertiary hospital in southeast China, 2009-2018
CONCLUSIONS: Staphylococcus aureus and Streptococcus pneumoniae were the leading cause of pleural empyema. Antimicrobial susceptibility testing revealed a high percentage of resistance against penicillin while vancomycin provided 100% coverage for these pathogens. Pseudomonas aeruginosa is the third most common pathogen mainly detected in those under 3 years old in the summer and have shown to be susceptible to ceftazidime. The prognosis is good after appropriate therapy.PMID:35023649 | DOI:10.24953/turkjped.2021.06.007 (Source: The Turkish Journal of Pediatrics)
Source: The Turkish Journal of Pediatrics - January 13, 2022 Category: Pediatrics Authors: Xueya Zhang Hailin Zhang Source Type: research
Microbiological characteristics and outcomes of children with pleural empyema admitted to a tertiary hospital in southeast China, 2009-2018
CONCLUSIONS: Staphylococcus aureus and Streptococcus pneumoniae were the leading cause of pleural empyema. Antimicrobial susceptibility testing revealed a high percentage of resistance against penicillin while vancomycin provided 100% coverage for these pathogens. Pseudomonas aeruginosa is the third most common pathogen mainly detected in those under 3 years old in the summer and have shown to be susceptible to ceftazidime. The prognosis is good after appropriate therapy.PMID:35023649 | DOI:10.24953/turkjped.2021.06.007 (Source: The Turkish Journal of Pediatrics)
Source: The Turkish Journal of Pediatrics - January 13, 2022 Category: Pediatrics Authors: Xueya Zhang Hailin Zhang Source Type: research
